136 related articles for article (PubMed ID: 33843468)
1. Effect of innate and adaptive immune mechanisms on treatment regimens in an AIDS-related Kaposi's Sarcoma model.
Chimbola OM; Lungu EM; Szomolay B
J Biol Dyn; 2021 Dec; 15(1):213-249. PubMed ID: 33843468
[TBL] [Abstract][Full Text] [Related]
2. A novel mathematical model of AIDS-associated Kaposi's sarcoma: Analysis and optimal control.
Kaondera-Shava RF; Lungu E; Szomolay B
Biosystems; 2021 Feb; 200():104318. PubMed ID: 33309554
[TBL] [Abstract][Full Text] [Related]
3. Human herpesvirus type 6 and cytomegalovirus in AIDS-associated Kaposi's sarcoma: no evidence for an etiological association.
Kempf W; Adams V; Pfaltz M; Briner J; Schmid M; Moos R; Hassam S
Hum Pathol; 1995 Aug; 26(8):914-9. PubMed ID: 7635454
[TBL] [Abstract][Full Text] [Related]
4. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
Goebel FD; Jablonowski H
Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
[TBL] [Abstract][Full Text] [Related]
5. Localization of human herpesvirus type 8 (HHV-8) in the Kaposi's sarcoma tissues and the semen specimens of HIV-1 infected and uninfected individuals by utilizing in situ polymerase chain reaction.
Bobroski L; Bagasra AU; Patel D; Saikumari P; Memoli M; Abbey MV; Wood C; Sosa C; Bagasra O
J Reprod Immunol; 1998 Dec; 41(1-2):149-60. PubMed ID: 10213307
[TBL] [Abstract][Full Text] [Related]
6. Association of IL-6, IL-10 and CXCL10 serum concentrations with visceral Kaposi's sarcoma in people living with HIV/AIDS.
Lopes TRR; Gonçales JP; Silva Júnior JVJ; Lorena VMB; Toscano ALCC; Akamatsu SM; Salles AC; Tozetto-Mendoza TR; Morais VMS; Coêlho MRCD
Hum Immunol; 2020 Jan; 81(1):26-31. PubMed ID: 31866063
[TBL] [Abstract][Full Text] [Related]
7. Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa.
Kasolo FC; Mpabalwani E; Gompels UA
J Gen Virol; 1997 Apr; 78 ( Pt 4)():847-55. PubMed ID: 9129658
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy.
Boivin G; Gaudreau A; Routy JP
AIDS; 2000 Sep; 14(13):1907-10. PubMed ID: 10997393
[TBL] [Abstract][Full Text] [Related]
9. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
10. HHV-8 DNA replication correlates with the clinical status in AIDS-related Kaposi's sarcoma.
Broccolo F; Tassan Din C; Viganò MG; Rutigliano T; Esposito S; Lusso P; Tambussi G; Malnati MS
J Clin Virol; 2016 May; 78():47-52. PubMed ID: 26985593
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study.
Martró E; Esteve A; Schulz TF; Sheldon J; Gambús G; Muñoz R; Whitby D; Casabona J;
Int J Cancer; 2007 Mar; 120(5):1129-35. PubMed ID: 17154170
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
[TBL] [Abstract][Full Text] [Related]
15. AIDS presenting with cutaneous Kaposi's sarcoma and bacillary angiomatosis in the bone marrow mimicking Kaposi's sarcoma.
Rosales CM; McLaughlin MD; Sata T; Katano H; Veno PA; de Las Casas LE; Miranda RN
AIDS Patient Care STDS; 2002 Dec; 16(12):573-7. PubMed ID: 12542930
[TBL] [Abstract][Full Text] [Related]
16. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
17. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.
Jacobson LP; Jenkins FJ; Springer G; Muñoz A; Shah KV; Phair J; Zhang Z; Armenian H
J Infect Dis; 2000 Jun; 181(6):1940-9. PubMed ID: 10837173
[TBL] [Abstract][Full Text] [Related]
18. Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma.
Corbellino M; Poirel L; Bestetti G; Pizzuto M; Aubin JT; Capra M; Bifulco C; Berti E; Agut H; Rizzardini G; Galli M; Parravicini C
AIDS Res Hum Retroviruses; 1996 May; 12(8):651-7. PubMed ID: 8744575
[TBL] [Abstract][Full Text] [Related]
19. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma.
Dupin N; Rubin De Cervens V; Gorin I; Calvez V; Pessis E; Grandadam M; Rabian C; Viard JP; Huraux JM; Escande JP
Br J Dermatol; 1999 May; 140(5):875-81. PubMed ID: 10354025
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients.
De Milito A; Catucci M; Venturi G; Romano L; Incandela L; Valensin PE; Zazzi M
J Med Virol; 1999 Feb; 57(2):140-4. PubMed ID: 9892398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
